Source: Pharmacy Times articles
Updates on April 30, 2025, introduce changes to treatment regimens, sequencing flexibility, febrile neutropenia risk assessments, and drug-specific safety and supportive care guidance.
Read More
by MM360 Staff | Apr 30, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Updates on April 30, 2025, introduce changes to treatment regimens, sequencing flexibility, febrile neutropenia risk assessments, and drug-specific safety and supportive care guidance.
Read More